세계의 폐 약물전달 디바이스 시장 보고서(2024년)

Pulmonary Drug Delivery Devices Global Market Report 2024

US $ 5,000 ￦ 7,095,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,643,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

폐 약물전달 디바이스 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2028년에는 CAGR 7.2%로 653억 3,000만 달러로 성장합니다. 예측 기간 중의 성장은 호흡기 치료에서 맞춤형 의료 및 정밀의료에 대한 수요 증가, 재택치료 서비스 및 원격 환자 모니터링의 확대, R&D 투자 증가, 예방 의료 및 조기 개입 전략에 대한 관심 증가 등에 기인할 것으로 보입니다. 예측 기간 중 주요 동향으로는 기술 혁신, 가치 기반 치료 모델 및 환자 중심 접근 방식으로의 전환, 호흡기 치료 플랫폼에 원격의료 및 원격 모니터링 기능의 통합, 호흡기 질환 자가 관리를 위한 웨어러블 및 모바일 애플리케이션의 사용, 3D 프린팅 및 디지털 제조 기술의 채택 등이 있습니다. 및 디지털 제조 기술 채택 등을 들 수 있습니다.

호흡기 질환의 유병률 증가는 향후 폐 약물전달 디바이스 시장의 성장을 가속할 것으로 예상됩니다. 호흡기 질환은 폐와 호흡기에 영향을 미치고 인간의 호흡을 손상시키는 질병 및 상태입니다. 호흡기 질환의 유병률 증가는 대기 오염 수준 증가, 흡연율 증가, 도시화, 기후 변화, 고령화 등 여러 요인에 기인합니다. 폐 약물전달 디바이스는 폐에 직접 약물을 전달할 수 있게 함으로써 호흡기 질환 치료에 중요한 역할을 하고 있습니다. 예를 들어 2024년 5월 미국 질병통제예방센터(CDC)는 18세 이상 성인의 현재 천식 유병률이 2021년 8.0%에서 2022년 8.7%로 증가할 것이라고 보고했습니다. 이처럼 호흡기 질환의 유병률 증가는 폐 약물전달 디바이스 시장의 성장을 가속할 것으로 예상됩니다.

폐 약물전달 디바이스 시장의 주요 기업은 소용량 분무기와 같은 혁신적인 제품을 개발하여 첨단 기능으로 고객에게 더 나은 서비스를 제공합니다. 소량 분무기(SVN)는 천식, 만성폐쇄성폐질환(COPD), 낭포성 섬유증과 같은 호흡기 질환 환자에게 에어로졸화된 미스트 형태로 액체 약물을 전달하는 데 사용되는 의료기기입니다. 예를 들어 2024년 5월 미국 헬스케어 기업 Medline Industries, LP는 Hudson RCI 터보 미스트 소용량 분무기를 출시했습니다. 이 획기적인 장비는 단 3분 만에 약물을 투여할 수 있도록 설계되었습니다. 이 혁신적인 분무기는 표준 분무기에 비해 분당 2.5배의 약물을 분출할 수 있으며, 치료 시간을 약 70% 단축할 수 있습니다. 이러한 약물 투여량 증가는 치료 시간을 크게 단축하고 환자의 처리 능력을 최적화하여 의료 서비스 프로바이더에게 혜택을 제공하고 치료 세션 시간을 단축하여 환자 경험을 향상시킵니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

• 세계의 폐 약물전달 디바이스 시장 : 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 폐 약물전달 디바이스 시장의 실적 : 규모와 성장, 2018-2023년
• 세계의 폐 약물전달 디바이스 시장의 예측 : 규모와 성장, 2023-2028년, 2033년

제6장 시장 세분화

• 세계의 폐 약물전달 디바이스 시장 : 제품 유형별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 드라이 파우더 흡입기
• 정량 흡입기
• 네뷸라이저
• 세계의 폐 약물전달 디바이스 시장 : 용도별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 천식
• 낭포성 섬유증
• 만성 폐쇄성 폐질환
• 기타 용도
• 세계의 폐 약물전달 디바이스 시장 : 유통 채널별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 소매 약국
• 병원 약국
• E-Commerce

제7장 지역별·국가별 분석

• 세계의 폐 약물전달 디바이스 시장 : 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 폐 약물전달 디바이스 시장 : 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 폐 약물전달 디바이스 시장 : 경쟁 구도
• 폐 약물전달 디바이스 시장 : 기업 개요
  • Medtronic plc
  • Air Liquide S.A.
  • Becton Dickinson and Company
  • Koninklijke Philips N.V.
  • Medline Industries Inc.

제31장 기타 대기업과 혁신적 기업

• ResMed Inc.
• Dragerwerk AG And Co. KGaA
• Smiths Group plc
• AptarGroup Inc.
• Chiesi Farmaceutici S.p.A.
• Teleflex Incorporated
• Masimo Corporation
• Fisher And Paykel Healthcare Limited
• Invacare Corporation
• Vyaire Medical Inc.
• Inogen Inc.
• Drive DeVilbiss Healthcare Inc.
• Hovione
• Hamilton Medical AG
• GaleMed Corporation

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재적 분석

제36장 부록

KSA

영문 목차

영문목차

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including the pulmonary drug delivery devices industry global market size, regional shares, competitors with pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. These pulmonary drug delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $46.27 billion in 2023 to $49.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to several factors, including the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, as well as the growing aging population worldwide. Additionally, increased awareness about the importance of respiratory health, expanded healthcare expenditure in emerging economies, and the increasing adoption of homecare settings for respiratory therapy have all contributed to this growth.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $65.33 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth during the forecast period can be attributed to the increasing demand for personalized and precision medicine in respiratory care, the expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and a growing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, a shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the use of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The growing prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market in the future. Respiratory disorders are diseases or conditions that affect the lungs and airways, impairing human respiration. The increasing prevalence of respiratory disorders is due to several factors, such as rising levels of air pollution, increased smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices play a crucial role in treating respiratory disorders by enabling direct medication delivery to the lungs. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that the prevalence of current asthma among adults aged 18 and over increased from 8.0% in 2021 to 8.7% in 2022. Thus, the rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In August 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2023. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
• 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
• 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
• Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson and Company; Koninklijke Philips N.V.; Medline Industries Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pulmonary Drug Delivery Devices Market Size and Growth

• 5.1. Global Pulmonary Drug Delivery Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pulmonary Drug Delivery Devices Market Segmentation

• 6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dry Powder Inhalers
• Metered Dose Inhalers
• Nebulizers
• 6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Asthma
• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease
• Other Applications
• 6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

• 8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

• 9.1. China Pulmonary Drug Delivery Devices Market Overview
• 9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

• 10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

• 11.1. Japan Pulmonary Drug Delivery Devices Market Overview
• 11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

• 12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

• 13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

• 14.1. South Korea Pulmonary Drug Delivery Devices Market Overview
• 14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

• 15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
• 15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

• 16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

• 17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

• 18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

• 19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

• 20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

• 21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

• 22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

• 23.1. North America Pulmonary Drug Delivery Devices Market Overview
• 23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

• 24.1. USA Pulmonary Drug Delivery Devices Market Overview
• 24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

• 25.1. Canada Pulmonary Drug Delivery Devices Market Overview
• 25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

• 26.1. South America Pulmonary Drug Delivery Devices Market Overview
• 26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

• 27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

• 28.1. Middle East Pulmonary Drug Delivery Devices Market Overview
• 28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

• 29.1. Africa Pulmonary Drug Delivery Devices Market Overview
• 29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape
• 30.2. Pulmonary Drug Delivery Devices Market Company Profiles
  • 30.2.1. Medtronic plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Air Liquide S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Becton Dickinson and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Koninklijke Philips N.V.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Medline Industries Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. ResMed Inc.
• 31.2. Dragerwerk AG And Co. KGaA
• 31.3. Smiths Group plc
• 31.4. AptarGroup Inc.
• 31.5. Chiesi Farmaceutici S.p.A.
• 31.6. Teleflex Incorporated
• 31.7. Masimo Corporation
• 31.8. Fisher And Paykel Healthcare Limited
• 31.9. Invacare Corporation
• 31.10. Vyaire Medical Inc.
• 31.11. Inogen Inc.
• 31.12. Drive DeVilbiss Healthcare Inc.
• 31.13. Hovione
• 31.14. Hamilton Medical AG
• 31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking

33. Global Pulmonary Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market Future Outlook and Potential Analysis

• 35.1 Pulmonary Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pulmonary Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pulmonary Drug Delivery Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료